Thomas F. Gajewski to Receptors, Interleukin-6
This is a "connection" page, showing publications Thomas F. Gajewski has written about Receptors, Interleukin-6.
Connection Strength
0.092
-
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
Score: 0.047
-
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19. J Immunother Cancer. 2020 04; 8(1).
Score: 0.045